尋找研究成果

在所有內容中搜尋

為 研究成果 進行篩選

搜尋概念
已選取的篩選器

出版年份

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011

作者

  • Wu-Chou Su
13 引文 斯高帕斯(Scopus)

Activity and safety of AZD3759 in EGFR-mutant non-small-cell lung cancer with CNS metastases (BLOOM): a phase 1, open-label, dose-escalation and dose-expansion study

Ahn, M. J., Kim, D. W., Cho, B. C., Kim, S. W., Lee, J. S., Ahn, J. S., Kim, T. M., Lin, C. C., Kim, H. R., John, T., Kao, S., Goldman, J. W., Su, W. C., Natale, R., Rabbie, S., Harrop, B., Overend, P., Yang, Z. & Yang, J. C. H., 2017 十一月, 於 : The Lancet Respiratory Medicine. 5, 11, p. 891-902 12 p.

研究成果: Article

34 引文 斯高帕斯(Scopus)
78 引文 斯高帕斯(Scopus)

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial

Yang, J. C. H., Shih, J. Y., Su, W. C., Hsia, T. C., Tsai, C. M., Ou, S. H. I., Yu, C. J., Chang, G. C., Ho, C. L., Sequist, L. V., Dudek, A. Z., Shahidi, M., Cong, X. J., Lorence, R. M., Yang, P. C. & Miller, V. A., 2012 五月 1, 於 : The Lancet Oncology. 13, 5, p. 539-548 10 p.

研究成果: Article

317 引文 斯高帕斯(Scopus)

Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): Analysis of overall survival data from two randomised, phase 3 trials

Yang, J. C. H., Wu, Y. L., Schuler, M., Sebastian, M., Popat, S., Yamamoto, N., Zhou, C., Hu, C. P., O'Byrne, K., Feng, J., Lu, S., Huang, Y., Geater, S. L., Lee, K. Y., Tsai, C. M., Gorbunova, V., Hirsh, V., Bennouna, J., Orlov, S., Mok, T. 及其他8, Boyer, M., Su, W. C., Lee, K. H., Kato, T., Massey, D., Shahidi, M., Zazulina, V. & Sequist, L. V., 2015 二月 1, 於 : The Lancet Oncology. 16, 2, p. 141-151 11 p.

研究成果: Article

849 引文 斯高帕斯(Scopus)

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): A phase 2b/3 randomised trial

Miller, V. A., Hirsh, V., Cadranel, J., Chen, Y. M., Park, K., Kim, S. W., Zhou, C., Su, W. C., Wang, M., Sun, Y., Heo, D. S., Crino, L., Tan, E. H., Chao, T. Y., Shahidi, M., Cong, X. J., Lorence, R. M. & Yang, J. C. H., 2012 五月 1, 於 : The Lancet Oncology. 13, 5, p. 528-538 11 p.

研究成果: Article

720 引文 斯高帕斯(Scopus)

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

Chao, Y., Hsieh, J. S., Yeh, H. T., Su, Y. C., Wu, C. C., Chen, J. S., Tai, C. J., Bai, L. Y., Yeh, K. H., Su, W. C. & Li, C. P., 2014 四月, 於 : Cancer Chemotherapy and Pharmacology. 73, 4, p. 799-806 8 p.

研究成果: Article

9 引文 斯高帕斯(Scopus)

A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer

Ko, A. H., Tempero, M. A., Shan, Y. S., Su, W. C., Lin, Y. L., Dito, E., Ong, A., Wang, Y. W., Yeh, C. G. & Chen, L. T., 2013 八月 20, 於 : British Journal of Cancer. 109, 4, p. 920-925 6 p.

研究成果: Article

110 引文 斯高帕斯(Scopus)

Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

Sampson, J. N., Wheeler, W. A., Yeager, M., Panagiotou, O., Wang, Z., Berndt, S. I., Lan, Q., Abnet, C. C., Amundadottir, L. T., Figueroa, J. D., Landi, M. T., Mirabello, L., Savage, S. A., Taylor, P. R., De Vivo, I., McGlynn, K. A., Purdue, M. P., Rajaraman, P., Adami, H. O., Ahlbom, A. 及其他388, Albanes, D., Amary, M. F., An, S. J., Andersson, U., Andriole, G., Andrulis, I. L., Angelucci, E., Ansell, S. M., Arici, C., Armstrong, B. K., Arslan, A. A., Austin, M. A., Baris, D., Barkauskas, D. A., Bassig, B. A., Becker, N., Benavente, Y., Benhamou, S., Berg, C., Van Den Berg, D., Bernstein, L., Bertrand, K. A., Birmann, B. M., Black, A., Boeing, H., Boffetta, P., Boutron-Ruault, M. C., Bracci, P. M., Brinton, L., Brooks-Wilson, A. R., Bueno-De-Mesquita, H. B., Burdett, L., Buring, J., Butler, M. A., Cai, Q., Cancel-Tassin, G., Canzian, F., Carrato, A., Carreon, T., Carta, A., Chan, J. K. C., Chang, E. T., Chang, G. C., Chang, I. S., Chang, J., Chang-Claude, J., Chen, C. J., Chen, C. Y., Chen, C., Chen, C. H., Chen, C., Chen, H., Chen, K., Chen, K. Y., Chen, K. C., Chen, Y., Chen, Y. H., Chen, Y. S., Chen, Y. M., Chien, L. H., Chirlaque, M. D., Choi, J. E., Choi, Y. Y., Chow, W. H., Chung, C. C., Clavel, J., Clavel-Chapelon, F., Cocco, P., Colt, J. S., Comperat, E., Conde, L., Connors, J. M., Conti, D., Cortessis, V. K., Cotterchio, M., Cozen, W., Crouch, S., Crous-Bou, M., Cussenot, O., Davis, F. G., Ding, T., Diver, W. R., Dorronsoro, M., Dossus, L., Duell, E. J., Ennas, M. G., Erickson, R. L., Feychting, M., Flanagan, A. M., Foretova, L., Fraumeni, J. F., Freedman, N. D., Freeman, L. E. B., Fuchs, C., Gago-Dominguez, M., Gallinger, S., Gao, Y. T., Gapstur, S. M., Garcia-Closas, M., García-Closas, R., Gascoyne, R. D., Gastier-Foster, J., Gaudet, M. M., Gaziano, J. M., Giffen, C., Giles, G. G., Giovannucci, E., Glimelius, B., Goggins, M., Gokgoz, N., Goldstein, A. M., Gorlick, R., Gross, M., Grubb, R., Gu, J., Guan, P., Gunter, M., Guo, H., Habermann, T. M., Haiman, C. A., Halai, D., Hallmans, G., Hassan, M., Hattinger, C., He, Q., He, X., Helzlsouer, K., Henderson, B., Henriksson, R., Hjalgrim, H., Hoffman-Bolton, J., Hohensee, C., Holford, T. R., Holly, E. A., Hong, Y. C., Hoover, R. N., Horn-Ross, P. L., Hosain, G. M. M., Hosgood, H. D., Hsiao, C. F., Hu, N., Hu, W., Hu, Z., Huang, M. S., Huerta, J. M., Hung, J. Y., Hutchinson, A., Inskip, P. D., Jackson, R. D., Jacobs, E. J., Jenab, M., Jeon, H. S., Ji, B. T., Jin, G., Jin, L., Johansen, C., Johnson, A., Jung, Y. J., Kaaks, R., Kamineni, A., Kane, E., Kang, C. H., Karagas, M. R., Kelly, R. S., Khaw, K. T., Kim, C., Kim, H. N., Kim, J. H., Kim, J. S., Kim, Y. H., Kim, Y. T., Kim, Y. C., Kitahara, C. M., Klein, A. P., Klein, R. J., Kogevinas, M., Kohno, T., Kolonel, L. N., Kooperberg, C., Kricker, A., Krogh, V., Kunitoh, H., Kurtz, R. C., Kweon, S. S., La Croix, A., Lawrence, C., Lecanda, F., Lee, V. H. F., Li, D., Li, H., Li, J., Li, Y. J., Li, Y., Liao, L. M., Liebow, M., Lightfoot, T., Lim, W. Y., Lin, C. C., Lin, D., Lindstrom, S., Linet, M. S., Link, B. K., Liu, C., Liu, J., Liu, L., Ljungberg, B., Lloreta, J., Di Lollo, S., Lu, D., Lund, E., Malats, N., Mannisto, S., Marchand, L. L., Marina, N., Masala, G., Mastrangelo, G., Matsuo, K., Maynadie, M., McKay, J., McKean-Cowdin, R., Melbye, M., Melin, B. S., Michaud, D. S., Mitsudomi, T., Monnereau, A., Montalvan, R., Moore, L. E., Mortensen, L. M., Nieters, A., North, K. E., Novak, A. J., Oberg, A. L., Offit, K., Oh, I. J., Olson, S. H., Palli, D., Pao, W., Park, I. K., Park, J. Y., Park, K. H., Patiño-Garcia, A., Pavanello, S., Peeters, P. H. M., Perng, R. P., Peters, U., Petersen, G. M., Picci, P., Pike, M. C., Porru, S., Prescott, J., Prokunina-Olsson, L., Qian, B., Qiao, Y. L., Rais, M., Riboli, E., Riby, J., Risch, H. A., Rizzato, C., Rodabough, R., Roman, E., Roupret, M., Ruder, A. M., De Sanjose, S., Scelo, G., Schned, A., Schumacher, F., Schwartz, K., Schwenn, M., Scotlandi, K., Seow, A., Serra, C., Serra, M., Sesso, H. D., Setiawan, V. W., Severi, G., Severson, R. K., Shanafelt, T. D., Shen, H., Shen, W., Shin, M. H., Shiraishi, K., Shu, X. O., Siddiq, A., Sierrasesúmaga, L., Sihoe, A. D. L., Skibola, C. F., Smith, A., Smith, M. T., Southey, M. C., Spinelli, J. J., Staines, A., Stampfer, M., Stern, M. C., Stevens, V. L., Stolzenberg-Solomon, R. S., Su, J., Su, W. C., Sund, M., Sung, J. S., Sung, S. W., Tan, W., Tang, W., Tardón, A., Thomas, D., Thompson, C. A., Tinker, L. F., Tirabosco, R., Tjønneland, A., Travis, R. C., Trichopoulos, D., Tsai, F. Y., Tsai, Y. H., Tucker, M., Turner, J., Vajdic, C. M., Vermeulen, R. C. H., Villano, D. J., Vineis, P., Virtamo, J., Visvanathan, K., Wactawski-Wende, J., Wang, C., Wang, C. L., Wang, J. C., Wang, J., Wei, F., Weiderpass, E., Weiner, G. J., Weinstein, S., Wentzensen, N., White, E., Witzig, T. E., Wolpin, B. M., Wong, M. P., Wu, C., Wu, G., Wu, J., Wu, T., Wu, W., Wu, X., Wu, Y. L., Wunder, J. S., Xiang, Y. B., Xu, J., Xu, P., Yang, P. C., Yang, T. Y., Ye, Y., Yin, Z., Yokota, J., Yoon, H. I., Yu, C. J., Yu, H., Yu, K., Yuan, J. M., Zelenetz, A., Zeleniuch-Jacquotte, A., Zhang, X. C., Zhang, Y., Zhao, X., Zhao, Z., Zheng, H., Zheng, T., Zheng, W., Zhou, B., Zhu, M., Zucca, M., Boca, S. M., Cerhan, J. R., Ferri, G. M., Hartge, P., Hsiung, C. A., Magnani, C., Miligi, L., Morton, L. M., Smedby, K. E., Teras, L. R., Vijai, J., Wang, S. S., Brennan, P., Caporaso, N. E., Hunter, D. J., Kraft, P., Rothman, N., Silverman, D. T., Slager, S. L., Chanock, S. J. & Chatterjee, N., 2015, 於 : Journal of the National Cancer Institute. 107, 12

研究成果: Article

70 引文 斯高帕斯(Scopus)

An increase in glucosylceramide synthase induces BclxL-mediated cell survival in vinorelbine-resistant lung adenocarcinoma cells

Chiu, W. H., Su, W. C., Li, C. L., Chen, C. L. & Lin, C. F., 2015 一月 1, 於 : Oncotarget. 6, 24, p. 20513-20524 12 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)

Annexin A2 silencing induces G2 arrest of non-small cell lung cancer cells through p53-dependent and -independent mechanisms

Wang, C. Y., Chen, C. L., Tseng, Y. L., Fang, Y. T., Lin, Y. S., Su, W. C., Chen, C. C., Chang, K. C., Wang, Y. C. & Lin, C. F., 2012 九月 21, 於 : Journal of Biological Chemistry. 287, 39, p. 32512-32524 13 p.

研究成果: Article

45 引文 斯高帕斯(Scopus)

An open-label, single-arm, phase 2 trial of the polo-like kinase inhibitor volasertib (BI 6727) in patients with locally advanced or metastatic urothelial cancer

Stadler, W. M., Vaughn, D. J., Sonpavde, G., Vogelzang, N. J., Tagawa, S. T., Petrylak, D. P., Rosen, P., Lin, C. C., Mahoney, J., Modi, S., Lee, P., Ernstoff, M. S., Su, W. C., Spira, A., Pilz, K., Vinisko, R., Schloss, C., Fritsch, H., Zhao, C. & Carducci, M. A., 2014 一月 1, 於 : Cancer. 120, 7, p. 976-982 7 p.

研究成果: Article

61 引文 斯高帕斯(Scopus)

An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan

Lee, K. D., Chen, H. H., Wang, H. M., Tsao, C. J., Hsu, T. C., Chiu, C. F., Su, W. C. & Wang, J. Y., 2013 五月 1, 於 : Oncology (Switzerland). 84, 5, p. 299-304 6 p.

研究成果: Article

2 引文 斯高帕斯(Scopus)

A novel derivative of betulinic acid, SYK023, suppresses lung cancer growth and malignancy

Hsu, T. I., Chen, Y. J., Hung, C. Y., Wang, Y-C., Lin, S. J., Su, W-C., Lai, M-D., Kim, S. Y., Wang, Q., Qian, K., Goto, M., Zhao, Y., Kashiwada, Y., Lee, K. H., Chang, W. C. & Hung, J-J., 2015 一月 1, 於 : Oncotarget. 6, 15, p. 13671-13687 17 p.

研究成果: Article

14 引文 斯高帕斯(Scopus)

A novel dielectrophoresis-based microfluidic chip for antibody-free isolation of circulating tumor cells from blood

Cheng, I. F., Chen, T. Y., Lin, Y. D., Huang, W. L., Liu, C. W. & Su, W. C., 2015 一月 1, IEEE-NANO 2015 - 15th International Conference on Nanotechnology. Institute of Electrical and Electronics Engineers Inc., p. 1525-1527 3 p. 7388934. (IEEE-NANO 2015 - 15th International Conference on Nanotechnology).

研究成果: Conference contribution

1 引文 斯高帕斯(Scopus)

Antibody-free isolation of rare cancer cells from blood based on 3D lateral dielectrophoresis

Cheng, I. F., Huang, W. L., Chen, T. Y., Liu, C. W., Lin, Y. D. & Su, W. C., 2015 七月 21, 於 : Lab on a Chip. 15, 14, p. 2950-2959 10 p.

研究成果: Article

43 引文 斯高帕斯(Scopus)

A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas

Lin, C. C., Arkenau, H. T., Lu, S., Sachdev, J., de Castro Carpeño, J., Mita, M., Dziadziuszko, R., Su, W. C., Bobilev, D., Hughes, L., Chan, J., Zhang, Z. Y. & Weiss, G. J., 2019 七月 16, 於 : British Journal of Cancer. 121, 2, p. 131-138 8 p.

研究成果: Article

開啟存取
2 引文 斯高帕斯(Scopus)

A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies

Lin, C. C., Su, W. C., Yen, C. J., Hsu, C. H., Su, W. P., Yeh, K. H., Lu, Y. S., Cheng, A. L., Huang, D. C. L., Fritsch, H., Voss, F., Taube, T. & Yang, J. C. H., 2014 五月 13, 於 : British Journal of Cancer. 110, 10, p. 2434-2440 7 p.

研究成果: Article

49 引文 斯高帕斯(Scopus)
35 引文 斯高帕斯(Scopus)

A randomized phase 2 study comparing the combination of ficlatuzumab and gefitinib with gefitinib alone in asian patients with advanced stage pulmonary adenocarcinoma

Mok, T. S. K., Geater, S. L., Su, W. C., Tan, E. H., Yang, J. C. H., Chang, G. C., Han, M., Komarnitsky, P., Payumo, F., Garrus, J. E., Close, S. & Park, K., 2016, 於 : Journal of Thoracic Oncology. 11, 10, p. 1736-1744 9 p.

研究成果: Article

23 引文 斯高帕斯(Scopus)

Association between GWAS-identified lung adenocarcinoma susceptibility loci and EGFR mutations in never-smoking Asian women, and comparison with findings from Western populations

Seow, W. J., Matsuo, K., Hsiung, C. A., Shiraishi, K., Song, M., NamKim, H., Wong, M. P., Hong, Y. C., Dean Hosgood, H., Wang, Z., Chang, I. S., Wang, J. C., Chatterjee, N., Tucker, M., Wei, H., Mitsudomi, T., Zheng, W., Kim, J. H., Zhou, B., Caporaso, N. E. 及其他166, Albanes, D., Shin, M. H., Chung, L. P., An, S. J., Wang, P., Zheng, H., Yatabe, Y., Zhang, X. C., Kim, Y. T., Shu, X. O., Kim, Y. C., Bassig, B. A., Chang, J., Man Ho, J. C., Ji, B. T., Kubo, M., Daigo, Y., Ito, H., Momozawa, Y., Ashikawa, K., Kamatani, Y., Honda, T., Sakamoto, H., Kunitoh, H., Tsuta, K., Watanabe, S. I., Nokihara, H., Miyagi, Y., Nakayama, H., Matsumoto, S., Tsuboi, M., Goto, K., Yin, Z., Shi, J., Takahashi, A., Goto, A., Minamiya, Y., Shimizu, K., Tanaka, K., Wu, T., Wei, F., Wong, J. Y. Y., Matsuda, F., Su, J., Kim, Y. H., Oh, I. J., Song, F., Lee, V. H. F., Su, W. C., Chen, Y. M., Chang, G. C., Chen, K. Y., Huang, M. S., Yang, P. C., Lin, H. C., Xiang, Y. B., Seow, A., Park, J. Y., Kweon, S. S., Chen, C. J., Li, H., Gao, Y. T., Wu, C., Qian, B., Lu, D., Liu, J., Jeon, H. S., Hsiao, C. F., Sung, J. S., Tsai, Y. H., Jung, Y. J., Guo, H., Hu, Z., Wang, W. C., Chung, C. C., Lawrence, C., Burdett, L., Yeager, M., Jacobs, K. B., Hutchinson, A., Berndt, S. I., He, X., Wu, W., Wang, J., Li, Y., Choi, J. E., Park, K. H., Sung, S. W., Liu, L., Kang, C. H., Hu, L., Chen, C. H., Yang, T. Y., Xu, J., Guan, P., Tan, W., Wang, C. L., Loon Sihoe, A. D., Chen, Y., Choi, Y. Y., Hung, J. Y., Kim, J. S., Yoon, H. I., Cai, Q., Lin, C. C., Park, I. K., Xu, P., Dong, J., Kim, C., He, Q., Perng, R. P., Chen, C. Y., Vermeulen, R., Wu, J., Lim, W. Y., Chen, K. C., Chan, J. K. C., Chu, M., Li, Y. J., Li, J., Chen, H., Yu, C. J., Jin, L., Lo, Y. L., Chen, Y. H., Fraumeni, J. F., Liu, J., Yamaji, T., Yang, Y., Hicks, B., Wyatt, K., Li, S. A., Dai, J., Ma, H., Jin, G., Song, B., Wang, Z., Cheng, S., Li, X., Ren, Y., Cui, P., Iwasaki, M., Shimazu, T., Tsugane, S., Zhu, J., Jiang, G., Fei, K., Wu, G., Chien, L. H., Chen, H. L., Su, Y. C., Tsai, F. Y., Chen, Y. S., Yu, J., Stevens, V. L., Laird-Offringa, I. A., Marconett, C. N., Lin, D., Chen, K., Wu, Y. L., Landi, M. T., Shen, H., Rothman, N., Kohno, T., Chanock, S. J. & Lan, Q., 2017, 於 : Human Molecular Genetics. 26, 2, p. 454-465 12 p.

研究成果: Article

21 引文 斯高帕斯(Scopus)
開啟存取
1 引文 斯高帕斯(Scopus)

AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer

Jänne, P. A., Chih-Hsin Yang, J., Kim, D. W., Planchard, D., Ohe, Y., Ramalingam, S. S., Ahn, M. J., Kim, S. W., Su, W. C., Horn, L., Haggstrom, D., Felip, E., Kim, J. H., Frewer, P., Cantarini, M., Brown, K. H., Dickinson, P. A., Ghiorghiu, S. & Ranson, M., 2015 四月 30, 於 : New England Journal of Medicine. 372, 18, p. 1689-1699 11 p.

研究成果: Article

1228 引文 斯高帕斯(Scopus)

Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of Sp1 to inhibit lung cancer growth

Hsu, T. I., Wang, M. C., Chen, S. Y., Huang, S. T., Yeh, Y-M., Su, W-C., Chang, W. C. & Hung, J-J., 2012 十二月 1, 於 : Molecular Pharmacology. 82, 6, p. 1115-1128 14 p.

研究成果: Article

46 引文 斯高帕斯(Scopus)

Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study

Hsu, C. H., Kang, Y. K., Yang, T. S., Shun, C. T., Shao, Y. Y., Su, W. C., Sandoval-Tan, J., Chiou, T. J., Jin, K., Hsu, C. & Cheng, A. L., 2013 七月 1, 於 : Oncology (Switzerland). 85, 1, p. 44-52 9 p.

研究成果: Article

34 引文 斯高帕斯(Scopus)
11 引文 斯高帕斯(Scopus)
開啟存取

Cabozantinib in hepatocellular carcinoma: Results of a phase 2 placebo-controlled randomized discontinuation study

Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T. S., Su, W. C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y. & Van Cutsem, E., 2017 一月 1, 於 : Annals of Oncology. 28, 3, p. 528-534 7 p.

研究成果: Article

57 引文 斯高帕斯(Scopus)

CDKN1A-mediated responsiveness of MLL-AF4-positive acute lymphoblastic leukemia to Aurora kinase-A inhibitors

Chen, Y. P., Lin, H. J., Chen, J. S., Tsai, M. Y., Hsieh, H. P., Chang, J. Y., Chen, N. F., Chang, K. C., Huang, W. T., Su, W. C., Yang, S. T., Chang, W. C., Hung, L. Y. & Chen, T. Y., 2014 八月 1, 於 : International Journal of Cancer. 135, 3, p. 751-762 12 p.

研究成果: Article

5 引文 斯高帕斯(Scopus)

Chemotherapeutics-induced Oct4 expression contributes to drug resistance and tumor recurrence in bladder cancer

Lu, C. S., Shieh, G. S., Wang, C. T., Su, B. H., Su, Y. C., Chen, Y. C., Su, W. C., Wu, P., Yang, W. H., Shiau, A. L. & Wu, C. L., 2017, 於 : Oncotarget. 8, 19, p. 30844-30858 15 p.

研究成果: Article

16 引文 斯高帕斯(Scopus)
3 引文 斯高帕斯(Scopus)
9 引文 斯高帕斯(Scopus)

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy

Chang, C. H., Hsiao, C. F., Yeh, Y-M., Chang, G. C., Tsai, Y. H., Chen, Y. M., Huang, M. S., Chen, H. L., Li, Y. J., Yang, P. C., Chen, C. J., Hsiung, C. A. & Su, W-C., 2013 五月 1, 於 : International Journal of Cancer. 132, 9, p. 1977-1985 9 p.

研究成果: Article

92 引文 斯高帕斯(Scopus)
開啟存取
5 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)
19 引文 斯高帕斯(Scopus)
4 引文 斯高帕斯(Scopus)
145 引文 斯高帕斯(Scopus)
7 引文 斯高帕斯(Scopus)
開啟存取
2 引文 斯高帕斯(Scopus)
23 引文 斯高帕斯(Scopus)

EGF-mediated inhibition of ubiquitin-specific peptidase 24 expression has a crucial role in tumorigenesis

Wang, S. A., Wang, Y. C., Chuang, Y. P., Huang, Y. H., Su, W. C., Chang, W. C. & Hung, J. J., 2017 五月 25, 於 : Oncogene. 36, 21, p. 2930-2945 16 p.

研究成果: Article

7 引文 斯高帕斯(Scopus)

EGFR exon 19 in-frame deletion and polymorphisms of DNA repair genes in never-smoking female lung adenocarcinoma patients

Yang, S. Y., Yang, T. Y., Li, Y. J., Chen, K. C., Liao, K. M., Hsu, K. H., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Shen, C. Y., Chang, G. C., Yang, P. C. 及其他1, Chen, C. J., 2013 一月 15, 於 : International Journal of Cancer. 132, 2, p. 449-458 10 p.

研究成果: Article

10 引文 斯高帕斯(Scopus)

EGFR L858R mutation and polymorphisms of genes related to estrogen biosynthesis and metabolism in never-smoking female lung adenocarcinoma patients

Yang, S. Y., Yang, T. Y., Chen, K. C., Li, Y. J., Hsu, K. H., Tsai, C. R., Chen, C. Y., Hsu, C. P., Hsia, J. Y., Chuang, C. Y., Tsai, Y. H., Chen, K. Y., Huang, M. S., Su, W. C., Chen, Y. M., Hsiung, C. A., Shen, C. Y., Chang, G. C., Yang, P. C. & Chen, C. J., 2011 四月 15, 於 : Clinical Cancer Research. 17, 8, p. 2149-2158 10 p.

研究成果: Article

22 引文 斯高帕斯(Scopus)

EGFR mutation analysis for prospective patient selection in AURA3 phase III trial of osimertinib versus platinum-pemetrexed in patients with EGFR T790M-positive advanced non-small-cell lung cancer

John, T., Akamatsu, H., Delmonte, A., Su, W. C., Lee, J. S., Chang, G. C., Huang, X., Jenkins, S. & Wu, Y. L., 2018 十二月, 於 : Lung Cancer. 126, p. 133-138 6 p.

研究成果: Article

6 引文 斯高帕斯(Scopus)

EGFR polymorphisms, hormone replacement therapy and lung adenocarcinoma risk: Analysis from a genome-wide association study in never-smoking women

Chen, K. Y., Hsiao, C. F., Chang, G. C., Tsai, Y. H., Su, W. C., Chen, Y. M., Huang, M. S., Hsiung, C. A., Chen, C. J. & Yang, P. C., 2013 三月, 於 : Carcinogenesis. 34, 3, p. 612-619 8 p.

研究成果: Article

15 引文 斯高帕斯(Scopus)